Lesser number of PCNA immunoreactivity was observed in metformin-treated mice, which accounted for 19% decrease (p < 0.05) in PCNA-positive cells compared with control (Figure 5C,D, left panel), demonstrating significant inhibitory effects of metformin on tumor cell proliferation in vivo. This evidence concerns the gene PCNA and neoplasm.